Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation.
Am J Trop Med Hyg
; 73(1): 166-70, 2005 Jul.
Article
en En
| MEDLINE
| ID: mdl-16014852
ABSTRACT
Malaria and anemia are common conditions in patients presenting to outpatient clinics in Kenya. Anemia is usually due to malaria infection with underlying micronutrient deficiency. Iron therapy has been shown to enhance recovery from anemia in children with malaria, without affecting malaria treatment. Iron and folic acid are often prescribed together for anemic individuals. Until recently in Kenya, the drug of first choice for non-severe malaria was sulfadoxine-pyrimethamine (SP), an antifolate antimalarial drug. In this study, 303 patients of all ages with anemia and uncomplicated Plasmodium falciparum malaria attending an outpatient clinic in an area of seasonal malaria were treated with SP and iron, and were randomized to receive folic acid. Parasite clearance rates were measured using a survival analysis plot for both parasitologic and clinical failure. There was a significant reduction in the efficacy of SP in patients taking standard therapeutic doses of folic acid using the survival curve for parasitologic failure (P < 0.0001), but no difference for clinical failure (P = 0.7008). Folic acid supplementation did not enhance recovery from anemia.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Contexto en salud:
2_ODS3
/
3_ND
/
4_TD
/
7_ODS3_muertes_prevenibles_nacidos_ninos
Problema de salud:
2_enfermedades_transmissibles
/
2_muertes_prevenibles
/
3_malaria
/
3_neglected_diseases
/
4_malaria
/
7_nutrition
Asunto principal:
Malaria Falciparum
/
Suplementos Dietéticos
/
Ácido Fólico
/
Malaria
/
Antimaláricos
Tipo de estudio:
Clinical_trials
/
Etiology_studies
Límite:
Animals
/
Child
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Am J Trop Med Hyg
Año:
2005
Tipo del documento:
Article
País de afiliación:
Kenia